Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TATAA Biocenter Expands its Digital PCR Offerings

Published: Tuesday, December 17, 2013
Last Updated: Tuesday, December 17, 2013
Bookmark and Share
Company expands its offerings with Bio-Rad’s Droplet Digital™ PCR system.

TATAA Biocenter is expanding its digital PCR offerings with Bio-Rad’s high-throughput QX200™ Droplet Digital™ PCR system (ddPCR™).

In 2007 TATAA Biocenter became the first company in Europe to provide digital PCR services to researchers and published one of the first papers that featured an application of digital PCR on a high throughput platform (Nucleic Acids Research 36: 387, 2008).

The paper discussed using digital PCR to measure intracellular mRNA gradients. TATAA also co-authored the Guidelines for Minimum Information for Publication of Quantitative Digital PCR Experiments (Clinical Chemistry 59:6, 2013). (publication names should be in italics).

“Digital PCR is most important complement to qPCR and can be used for standardization, copy number variation, and rare mutation analysis,” said Dr. Mikael Kubista, founder and CEO of TATAA Biocenter.

Dr. Kubista continued, “We have previously adopted the OpenArray and BioMark digital PCR platforms from Life Technologies and Fluidigm, which offer simultaneous measurements of qPCR and highly specific and sensitive dPCR analysis; however, with Bio-Rad’s QX200 system we can now offer dPCR in high throughput, using a much larger number of partitions. This is major strengthening of our service and training offerings.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TATAA Biocenter, Yikon Partner
TATAA Biocenter and Yikon Genomics has Announced Strategic Partnership to distribute Yikon’s MALBACTM products for single cell profiling and YK-PGSTM Solutions in Europe.
Tuesday, February 09, 2016
TATAA Partners with Qlucore
TATAA Biocenter introduces partnership with Qlucore to use Qlucore Omics Explorer in its Next Generation Sequencing courses and client services.
Monday, March 09, 2015
TATAA Biocenter Awarded for Best-in-Class Gene Expression Profiling Services
Numerous accreditations from diverse institutes and customer validations lend credibility to its educational programs.
Wednesday, August 21, 2013
TATAA Strengthens Quality Assurance Program
TATAA Biocenter expands offerings using AATI’s Fragment Analyzer™ to assess RNA quality in gene expression analysis.
Tuesday, May 21, 2013
TATAA Biocenter Introduces Ingenuity Systems iReport into qPCR Workflow
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™.
Wednesday, January 23, 2013
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!